Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 2640 results found. Search for [ pharma stocks ]

Results 2580 to 2600 of 2640
Dipen Sheth
May 15, 2008
Our model portfolios have generated a lot of interest among readers. Dipen Sheth answers some of the more prolific and profound among them.


Mudar Patherya
May 15, 2008
A growing portfolio of brands, expansion into more states and bigger orders from its MNC and Indian clients will ensure that Twilight Litaka Pharma’s revenues more than double to Rs 475 crore by 2009-10.


R Sree Ram
May 15, 2008
Corporate results are worse than before but better than expected. Best of all, despite the definitive slowdown, stocks remain the best investment.


www.businesstoday.in
April 4, 2008
Investors with two years or longer investment horizon and even a moderate tolerance for volatility should consider investing in stocks now, says Prashant Jain. We present two papers written by him in January and March 2008.


www.businesstoday.in
April 3, 2008
Periodic spurts notwithstanding, stock prices are down 25% from their peak. Learn what to do now.Why aren’t you panicky?A tempting opportunityWhy and when to sell stocksFeb 21 cover story: Riding the market swing


www.businesstoday.in
April 2, 2008
Tata Motors script is on the fall, on back of its acquisition of Jaguar and Land Rover with the company looking at availing a bridge loan for the $2.3 billion deal.


www.businesstoday.in
March 20, 2008
Pharma stocks have begun to rally again, on the back of some support in the Budget; read on to know more.


www.businesstoday.in
March 7, 2008
Read the impact on stocks of nine sectors that are likely to be most affected by the Budget proposals. We also list out some of the stocks in each sector that you might want to consider buying or selling.


www.businesstoday.in
March 7, 2008
The small-cap universe is a treasure trove of bargains—provided you can spot them. Between the four stocks listed on this page and the one that Mudar Patherya analyses in detail in his column, we will track five small-cap stocks in every issue.


www.businesstoday.in
February 7, 2008
We scan dozens of research reports from investment houses every fortnight to present you the six most relevant stock recommendations.


Tanvi Varma/Money Today
January 23, 2008
Like IT, most pharma funds have underperformed in a booming market. What should the investor do right now — sell, hold or buy? Here are some answers.


Dipen Sheth
December 26, 2007
Besides some new shares, our fund manager increases exposure to a few companies that will continue to be the engine of India’s growth story.


Narayan Krishnamurthy and Devangshu Datta
December 12, 2007
We revisit India's most wanted stocks and find out which are the favourite stocks of fund managers and the hottest sectors they are investing your money in.


Dipen Sheth
December 11, 2007
Reinforcing beliefs in blue chips, more shares of two Sensex heavyweights are accumulated, while some underperformers are sold.


Dipen Sheth
December 10, 2007
Keep in mind that even fund managers steering those massive mutual funds can go wrong. They are after all human and can be misled by erroneous and (sometimes) devious information they get from managements and analysts.


Dipen Sheth
November 27, 2007
Reacting to the recent volatility in the mid-cap sector, and wary of more in the global financial markets, we book profits in a number of shares.


By Dipen Sheth
October 13, 2007
You can’t ignore (FII) money that owns 27% of the Sensex. This (and not your Indian money) will also get a free ‘carry-ride’ as the rupee appreciates, and will decide what will happen to your portfolio.


www.businesstoday.in
October 5, 2007
Visakhapatnam-based naval officer Srinivas Ganapathi should continue investing in equities through mutual funds to build his dream corpus of Rs 3 crore.


By Dipen Sheth
October 4, 2007
With volatility ebbing from the markets, it is time to stay put with our pickings, but with minor changes.


www.businesstoday.in
September 20, 2007
Enam Securities feels that most pharma companies will continue with lukewarm performance in 2007.


PAGES 130 OF 132  126127128129130